Frontiers in Pharmacology | Drugs Outcomes Research and Policies

Original Research

Published on 17 Jul 2020

Validation of the General Medication Adherence Scale in Pakistani Patients With Rheumatoid Arthritis

in Drugs Outcomes Research and Policies

Atta Abbas Naqvi
Mohamed Azmi Hassali
Mehwish Rizvi
Ale Zehra
Zeb-un- Nisa
Md. Ashraful Islam
Muhammad Shahid Iqbal
Maryam Farooqui
Mohammad Tarique Imam
Mohammad Akbar Hossain

Frontiers in Pharmacology

doi 10.3389/fphar.2020.01039

8,496 views
18 citations

Systematic Review

Published on 16 Jul 2020

Artificial Intelligence in Pharmacoepidemiology: A Systematic Review. Part 1—Overview of Knowledge Discovery Techniques in Artificial Intelligence

in Drugs Outcomes Research and Policies

Maurizio Sessa
Abdul Rauf Khan
David Liang
Morten Andersen
Murat Kulahci

Frontiers in Pharmacology

doi 10.3389/fphar.2020.01028

10,501 views
20 citations

Methods

Published on 15 Jul 2020

Development of Comprehensible Prescription Label Instructions: A Study Protocol for a Mixed-Methods Approach

in Drugs Outcomes Research and Policies

Ekram Maghroudi
Charlotte M. J. van Hooijdonk
Liset van Dijk
Gudule Boland
Channah de Haas
Marleen Journée-Gilissen
Janneke van der Velden
Marcia Vervloet
Henk Westerhof
Jany J. D. J. M. Rademakers

Frontiers in Pharmacology

doi 10.3389/fphar.2020.00981

5,150 views
4 citations

Original Research

Published on 14 Jul 2020

Quantitative Systems Pharmacology Model-Based Predictions of Clinical Endpoints to Optimize Warfarin and Rivaroxaban Anti-Thrombosis Therapy

in Drugs Outcomes Research and Policies

Sonja Hartmann
Konstantinos Biliouris
Lawrence J. Lesko
Ulrike Nowak-Göttl
Mirjam N. Trame

Frontiers in Pharmacology

doi 10.3389/fphar.2020.01041

4,489 views
14 citations

Original Research

Published on 14 Jul 2020

Serious Inadequacies in High Alert Medication-Related Knowledge Among Pakistani Nurses: Findings of a Large, Multicenter, Cross-sectional Survey

in Drugs Outcomes Research and Policies

Muhammad Salman
Zia Ul Mustafa
Alina Zeeshan Rao
Qurat-ul-Ain Khan
Noman Asif
Khalid Hussain
Naureen Shehzadi
Muhammad Farhan Ali Khan
Amir Rashid

Frontiers in Pharmacology

doi 10.3389/fphar.2020.01026

9,834 views
23 citations

Clinical Trial

Published on 14 Jul 2020

No Statistically Apparent Difference in Antiviral Effectiveness Observed Among Ribavirin Plus Interferon-Alpha, Lopinavir/Ritonavir Plus Interferon-Alpha, and Ribavirin Plus Lopinavir/Ritonavir Plus Interferon-Alpha in Patients With Mild to Moderate Coronavirus Disease 2019: Results of a Randomized, Open-Labeled Prospective Study

in Drugs Outcomes Research and Policies

Yin-Qiu Huang
Sheng-Quan Tang
Xiao-Lei Xu
Yan-Ming Zeng
Xiao-Qing He
Yao Li
Vijay Harypursat
Yan-Qiu Lu
Yan Wan
Lu Zhang

Frontiers in Pharmacology

doi 10.3389/fphar.2020.01071

9,520 views
44 citations

Original Research

Published on 09 Jul 2020

Uptake of Biosimilar Infliximab in the UK, France, Japan, and Korea: Budget Savings or Market Expansion Across Countries?

in Drugs Outcomes Research and Policies

Yujeong Kim
Hye-Young Kwon
Brian Godman
Evelien Moorkens
Steven Simoens
SeungJin Bae

Frontiers in Pharmacology

doi 10.3389/fphar.2020.00970

12,929 views
50 citations

Clinical Trial

Published on 08 Jul 2020

Tolerability, Safety, Pharmacokinetics and Drug Interaction of Cefotaxime Sodium–Tazobactam Sodium Injection (6:1) Following Single and Multiple Intravenous Doses in Chinese Healthy Subjects

in Drugs Outcomes Research and Policies

Ning Chen
Lu-Ning Sun
Wen-Hui Hu
Yi-Ya Wang
Li-Jun Xie
Juan Cheng
Hong-Wen Zhang
Yun Liu
Yong-Qing Wang
Li Ding

Frontiers in Pharmacology

doi 10.3389/fphar.2020.01033

4,129 views
4 citations

Original Research

Published on 02 Jul 2020

Assessment of a Model-Informed Precision Dosing Platform Use in Routine Clinical Care for Personalized Busulfan Therapy in the Pediatric Hematopoietic Cell Transplantation (HCT) Population

in Drugs Outcomes Research and Policies

Praveen Shukla
Srijib Goswami
Ron J. Keizer
Beth Apsel Winger
Sandhya Kharbanda
Christopher C. Dvorak
Janel Long-Boyle

Frontiers in Pharmacology

doi 10.3389/fphar.2020.00888

6,392 views
29 citations

Systematic Review

Published on 30 Jun 2020

What Is the Most Appropriate Induction Regimen for the Treatment of HIV-Associated Cryptococcal Meningitis When the Recommended Regimen Is Not Available? Evidence From a Network Meta-Analysis

in Drugs Outcomes Research and Policies

Yao Li
Xiaojie Huang
Yuanyuan Qin
Hao Wu
Xiaofeng Yan
Yaokai Chen

Frontiers in Pharmacology

doi 10.3389/fphar.2020.00963

3,184 views
6 citations

Policy and Practice Reviews

Published on 30 Jun 2020

Practice Guidelines for Clinical Pharmacists in Middle to Low Income Countries

in Drugs Outcomes Research and Policies

Elmien Bronkhorst
Andries G. S. Gous
Natalie Schellack

Frontiers in Pharmacology

doi 10.3389/fphar.2020.00978

15,464 views
21 citations

Original Research

Published on 26 Jun 2020

Registered Interventional Clinical Trials for Old Populations With Infectious Diseases on ClinicalTrials.gov: A Cross-Sectional Study

in Drugs Outcomes Research and Policies

Lingmin Chen
Menghua Wang
Yi Yang
Jing Shen
Yonggang Zhang

Frontiers in Pharmacology

doi 10.3389/fphar.2020.00942

4,870 views
10 citations

Systematic Review

Published on 24 Jun 2020

Efficacy and Safety of Recombinant Human Thrombopoietin on Sepsis Patients With Thrombocytopenia: A Systematic Review and Meta-Analysis

in Drugs Outcomes Research and Policies

Jin Zhang
Zongqing Lu
Wenyan Xiao
Tianfeng Hua
Yao Zheng
Min Yang

Frontiers in Pharmacology

doi 10.3389/fphar.2020.00940

5,371 views
12 citations

Systematic Review

Published on 24 Jun 2020

Effectiveness and Safety of Anti-Tumor Necrosis Factor-Alpha Agents Treatment in Behcets’ Disease-Associated Uveitis: A Systematic Review and Meta-Analysis

in Drugs Outcomes Research and Policies

Yunwei Hu
Zhaohao Huang
Shizhao Yang
Xiaoqing Chen
Wenru Su
Dan Liang

Frontiers in Pharmacology

doi 10.3389/fphar.2020.00941

6,041 views
38 citations

Review

Published on 18 Jun 2020

Artificial Intelligence and Machine Learning Applied at the Point of Care

in Drugs Outcomes Research and Policies

Zuzanna Angehrn
Liina Haldna
Anthe S. Zandvliet
Eva Gil Berglund
Joost Zeeuw
Billy Amzal
S. Y. Amy Cheung
Thomas M. Polasek
Marc Pfister
Thomas Kerbusch

Frontiers in Pharmacology

doi 10.3389/fphar.2020.00759

17,208 views
74 citations

Original Research

Published on 17 Jun 2020

Can Standardisation of the Public Assessment Report Improve Benefit-Risk Communication?

in Drugs Outcomes Research and Policies

Andrea Keyter
Sam Salek
Shabir Banoo
Stuart Walker

Frontiers in Pharmacology

doi 10.3389/fphar.2020.00855

3,654 views
8 citations

Navigation group

Articles

Validation of the General Medication Adherence Scale in Pakistani Patients With Rheumatoid Arthritis

Artificial Intelligence in Pharmacoepidemiology: A Systematic Review. Part 1—Overview of Knowledge Discovery Techniques in Artificial Intelligence

Development of Comprehensible Prescription Label Instructions: A Study Protocol for a Mixed-Methods Approach

Quantitative Systems Pharmacology Model-Based Predictions of Clinical Endpoints to Optimize Warfarin and Rivaroxaban Anti-Thrombosis Therapy

Serious Inadequacies in High Alert Medication-Related Knowledge Among Pakistani Nurses: Findings of a Large, Multicenter, Cross-sectional Survey

Uptake of Biosimilar Infliximab in the UK, France, Japan, and Korea: Budget Savings or Market Expansion Across Countries?

Tolerability, Safety, Pharmacokinetics and Drug Interaction of Cefotaxime Sodium–Tazobactam Sodium Injection (6:1) Following Single and Multiple Intravenous Doses in Chinese Healthy Subjects

Assessment of a Model-Informed Precision Dosing Platform Use in Routine Clinical Care for Personalized Busulfan Therapy in the Pediatric Hematopoietic Cell Transplantation (HCT) Population

What Is the Most Appropriate Induction Regimen for the Treatment of HIV-Associated Cryptococcal Meningitis When the Recommended Regimen Is Not Available? Evidence From a Network Meta-Analysis

Practice Guidelines for Clinical Pharmacists in Middle to Low Income Countries

Registered Interventional Clinical Trials for Old Populations With Infectious Diseases on ClinicalTrials.gov: A Cross-Sectional Study

Efficacy and Safety of Recombinant Human Thrombopoietin on Sepsis Patients With Thrombocytopenia: A Systematic Review and Meta-Analysis

Effectiveness and Safety of Anti-Tumor Necrosis Factor-Alpha Agents Treatment in Behcets’ Disease-Associated Uveitis: A Systematic Review and Meta-Analysis

Artificial Intelligence and Machine Learning Applied at the Point of Care

Can Standardisation of the Public Assessment Report Improve Benefit-Risk Communication?